| Vol. 6.36 – 19 October, 2020 |
| |
|
|
| Scientists describe ways to overcome obstacles in the context of normal human skin, offering a glimpse into the genomic landscapes of individual melanocytes from human skin. [Nature] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
| DERMAL STEM CELLS & TISSUE REGENERATION |
| | Investigators used Seq-Well S3 (“Second-Strand Synthesis”) to chart the transcriptional landscape of five human inflammatory skin diseases, providing a resource for the further study of human skin inflammation. [Immunity] |
| | Scientists showed that the poorly characterized herpes simplex virus 1 pUL56 directly binds Golgi-associated PDZ and coiled-coil motif-containing protein (GOPC), stimulating its ubiquitination and proteasomal degradation. [Cell Reports] |
| | Arp3 depletion in the melanocyte lineage resulted in severe pigmentation defects in dorsal and ventral regions of the mouse skin. [Development] |
| | Using a human dermal fibroblast cell line in suspension culture, investigators found that high hydrostatic pressure at 50 MPa for ≥ 36 hours completely induced fibroblast cell death via apoptosis based on the morphological changes in transmission electron microscopy, reactive oxygen species elevation, caspase activation and phosphatidylserine membrane translocation. [Scientific Reports] |
| |
|
|
| Midkine was found to control the transcriptome of melanoma cells, allowing for coordinated activation of nuclear factor-κB and downregulation of interferon-associated pathways. [Nature Medicine] |
|
|
|
| The authors used single cell RNA-sequencing of patient tumors to identify three prognostic surface markers (LYPD3, TACSTD2, and LY6D) which correlated with nuclear myocardin-related transcription factor (nMRTF) and resistance to Smoothened inhibitors. The nMRTF cell state resembled transit-amplifying cells of the hair follicle matrix, with AP-1 and TGFß cooperativity driving nMRTF activation. [Nature Communications] |
|
|
|
| Researchers report that cancer associated fibroblasts from skin squamous cell carcinomas displayed chromosomal alterations, with heterogeneous NOTCH1 gene amplification and overexpression that also occurred, to a lesser extent, in dermal fibroblasts of unaffected skin. [Nature Communications] |
|
|
|
| An increase in heme oxygenase-1 protein was recapitulated in human A375 melanoma cells exposed to fructose in culture. [Cancer Immunology Research] |
|
|
|
| The anti-melanoma activity of Nicotinamide, the amide form of Niacin, was assessed in vitro and in vivo. [Journal of Experimental & Clinical Cancer Research] |
|
|
|
| Scientists presented a multiparameter genome-wide siRNA screening dataset of genes that when depleted, improved the viability and glycolytic response to vemurafenib in BRAFV600 mutated melanoma cells. [Scientific Data] |
|
|
|
| In vitro, Oncostatin M promoted invasiveness of keratinocytes and cutaneous squamous cell carcinoma cells and suppressed apoptosis of irradiated keratinocytes. [Scientific Reports] |
|
|
|
|
| The authors present an overview of the mechanisms that result in the transcriptional deregulation of mRNA expression in melanoma cells and assess how these changes facilitate melanoma initiation and progression. [Oncogene] |
|
|
|
| Investigators review new insights regarding the pathogenesis of psoriasis, as it relates to dendritic cells, Langerhans cells, macrophages, the signal transducer and activator of transcription 3 pathway, and aryl hydrocarbon receptor in cutaneous vascular endothelial cells. [International Journal of Molecular Sciences] |
|
|
|
|
| The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for Dupixent®, recommending to extend the approval in the European Union to include children aged 6 to 11 years with severe atopic dermatitis who are candidates for systemic therapy. [CHMP (Globe Newswire, Inc)] |
|
|
|
| AbbVie, Inc submitted applications to the US FDA and European Medicines Agency (EMA) seeking approval for RINVOQ™ for the treatment of adults and adolescents with moderate to severe atopic dermatitis. [AbbVie, Inc] |
|
|
|
|
| January 9 – January 12, 2021 Lake Buena Vista, Florida, United States |
|
|
|
|
|
| University of Alabama at Birmingham – Birmingham, Alabama, United States |
|
|
|
| King’s College London – London, England, United Kingdom |
|
|
|
| The University of Chicago – Chicago, Illinois, United States |
|
|
|
| University of California, Davis – Sacramento, California, United States |
|
|
|
| Sanford Burnham Prebys Medical Discovery Institute – La Jolla, California, United States |
|
|
|
|